Product Overview: CLENBUTEROL ASLAN PHARMA
Clenbuterol is a beta-2 adrenergic receptor agonist extensively studied for its sympathomimetic properties and metabolic effects in laboratory research. This Aslan Pharma formulation enables researchers at Stroid UK Shop to investigate beta-adrenergic signalling pathways and thermogenic responses in controlled experimental conditions. The compound demonstrates high selectivity for beta-2 receptors compared to beta-1 subtypes, making it valuable for examining tissue-specific adrenergic responses. Laboratory studies have examined clenbuterol’s effects on cyclic adenosine monophosphate (cAMP) elevation, protein kinase A activation, and downstream metabolic cascades in various cell culture models.
Laboratory Applications
Researchers examine clenbuterol’s mechanisms in metabolic studies focusing on lipolysis, thermogenesis, and energy expenditure pathways. The compound serves as a research tool for investigating beta-2 receptor pharmacology, particularly in studies examining receptor desensitisation, coupling efficiency, and G-protein signalling dynamics. Scientists studying fat burner compounds utilise clenbuterol to evaluate sympathetic nervous system modulation and its effects on metabolic rate in experimental models. Research applications include examining bronchodilatory mechanisms, cardiac beta-receptor responses, and skeletal muscle protein synthesis pathways. Comparative studies with SARMs and peptides help elucidate different approaches to metabolic modulation research.
Product Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | (RS)-1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol |
| CAS Number | 37148-27-9 |
| Molecular Formula | C₁₂H₁₈Cl₂N₂O |
| Molecular Weight | 277.19 g/mol |
| Storage Temperature | Room temperature, dry environment |
| Manufacturer | Aslan Pharma |
| Research Grade | Laboratory standard |
Research Compliance
This clenbuterol formulation is manufactured by Aslan Pharma exclusively for in-vitro research applications and laboratory studies. The product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and appropriate safety protocols when handling this beta-2 agonist compound. All studies should be conducted by qualified personnel in appropriate research facilities with proper ventilation and safety equipment.
